Bromazolam Powder Sales

Buy Bromazolam Powder Online

  • Purchase Bromazolam Powder Online

    Purchase Bromazolam Powder Online

    Purchase Bromazolam Powder Online. What is Bromazolam? Bromazolam was first synthesized back in 1976, but was never commercially marketed and not identified until much later in the early 2000s by the EMCDDA in Sweden.Also known as 8-bromo-6-phenyl-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine or XLI-268, Buy Bromazolam online always available.It shares most of its structural properties with Alprazolam (brand…

  • Buy U-47700 opioid suppliers

    Buy U-47700 opioid suppliers

    Buy U-47700 opioid suppliers U-47700, also known as U4, pink heroin, pinky, and pink, is an opioid analgesic drug developed by a team at Upjohn in the 1970s which has around 7.5 times the potency of morphine in animal models. U-47700 is a structural isomer of the earlier opioid AH-7921[6] and the result of a great deal of work elucidating the quantitative structure–activity relationship of the scaffold. Upjohn looked for the…

  • Buy 4-Fluoromethylphenidate  4-FMPH  4F-MPH

    Buy 4-Fluoromethylphenidate  4-FMPH  4F-MPH

    Buy 4-Fluoromethylphenidate  4-FMPH  4F-MPH. 4-Fluoromethylphenidate (also known as 4-FMPH and 4F-MPH) is a stimulant drug that acts as a higher potency dopamine reuptake inhibitor than the closely related methylphenidate.[2][3][4] 4-Fluoromethylphenidate was studied further along with other analogues of (±)-threo-methylphenidate (TMP) to assess their potential as anti-cocaine medications. 4F-MPH was reported as having an ED50 mg/kg of 0.26 (0.18–0.36), regarding its efficacy as a substitute for cocaine, and a relative…

  • Buy Diclazepam chlorodiazepam powder

    Buy Diclazepam chlorodiazepam powder

    Buy Diclazepam chlorodiazepam powder Diclazepam (Ro5-3448), also known as chlorodiazepam and 2′-chloro-diazepam, is a benzodiazepine and functional analog of diazepam. It was first synthesized by Leo Sternbach and his team at Hoffman-La Roche in 1960. It is not currently approved for use as a medication, but rather sold as an unscheduled substance. Efficacy and safety have not been tested in humans. Names: Diclazepamchlorodiazepam, 7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-oneRo5-3448 IUPAC name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one Substance group:…

  • Buy CAS 148553-50-8  Pregabalin Lyrica

    Buy CAS 148553-50-8  Pregabalin Lyrica

    Buy CAS 148553-50-8  Pregabalin Lyrica. Pregabalin, sold under the brand name Lyrica among others, is an anticonvulsant, analgesic, and anxiolytic amino acid medication used to treat epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, opioid withdrawal, and generalized anxiety disorder (GAD). Pregabalin also has antiallodynic properties.[19][20][21] Its use in epilepsy is as an add-on therapy for partial seizures.[13] It is a gabapentinoid medication (GABA analogue) which are drugs that are derivatives of γ-aminobutyric acid (GABA), an inhibitory neurotransmitter. Pregabalin acts by inhibiting certain calcium channels. When used…

  • Buy Benzocaine CAS 94-09-7

    Buy Benzocaine CAS 94-09-7

    Buy Benzocaine CAS 94-09-7. Buy Benzocaine HCl powder (CAS-23239-88-5) Buy Benzocaine HCl powder (CAS-23239-88-5). Benzocaine for sale, sold under the brand name Orajel amongst others, is an ester local anesthetic commonly used as a topical pain reliever or in cough drops. It is the active ingredient in many over-the-counter anesthetic ointments such as products for oral…

  • Buy Phenacetin  Cas 62-44-2

    Buy Phenacetin  Cas 62-44-2

    Buy Phenacetin  Cas 62-44-2. Buy wholesale Phenacetin Crystal and Powder CAS 62-44-2 Phenacetin powder for sale. Buy wholesale Phenacetin Crystal and Powder CAS 62-44-2. Phenacetin (Acetophenetidin) is a non-opioid analgesic/antipyretic agent. Phenacetin is a selective COX-3 inhibitor. Phenacetin is used as probe of cytochrome P450 enzymes CYP1A2 in human liver microsomes and in rats. Phenacetin (acetophenetidin, N-(4-ethoxyphenyl)acetamide) is a…

Sell Bromazolam Powder Online

About Us.

Bromazolam Powder Sales is one of the largest Supplier, Agent and Distributors of Bromazolam powder online , Pharmaceutical Intermediates, Dissociatives, Chemical Reagent, Acid & Alkaline, Inorganic Chemical Materials, Food Additives, Stimulants, Plant Extract, Raw Steroid Hormones, API in Hongkong and other locations like mainland China, Vietnam and Taiwan. Bromazolam Powder Sales has been adhering to the business philosophy of providing the best products, the most efficient service and the most reasonable price for the customers since its establishment in 2014. Our company is specialized in supplies of starting materials and intermediaries of steroid hormone by bio-conversion, API and intermediate chemical synthesis. More to that, our manufacturers have three R&D centers, which are located at Fermentation FactoryChemical Synthesis Factory. New product development, process research and process optimization can be carried out at the same time. And it realizes the development, laboratory scale production and pilot production from grams, kilograms to tons. Based on the principle of ecology priority and green development, our company has continuously invested in environmental protection, developed and applied green production process, insistently strengthened pollution management and constantly consolidated the foundation for the operation and development over the years. The future will be better and better, we will continue to make our due contribution to human health by science and sincerity uses.

We Ship from Hongkong, Taiwan & Vietnam Safely. No shipping from Mainland China for Now!!!

What is Bromazolam ?

Bromazolam (XLI-268) is a triazolobenzodiazepine (TBZD) which was first synthesised in 1976, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016. It is the bromo instead of chloro analogue of alprazolam and has similar sedative and anxiolytic effects to it and other benzodiazepines. Bromazolam is a non subtype selective agonist at the benzodiazepine site of GABAA receptors, with a binding affinity of 2.81 nM at the α1 subtype, 0.69 nM at α2 and 0.62 nM at α5.The “common” dosage range for users of bromazolam was reported to be 1–2 mg, suggesting its potency is similar to alprazolam.

Adverse effects

Because bromazolam is relatively new, epidemiologically research regarding the individual’s health effects as well as the effects on the public health are quite scarce. Most of the knowledge about the effects are known from case studies and individual reports.

The typical effects of benzodiazepines used in medical science are muscle relaxation, amnesia, sedation, anxiolysis and anticonvulsive activity (used to treat epilepsy). Therefore are benzodiazepines frequently used to treat illnesses such as anxiety, insomnia, muscle spasms or epilepsy.

According to studies even short use of bromazolam could lead to tolerance and psychological, as well as physical dependence. Benzodiazepine-like compounds are rarely fatal when taken alone but can cause central nervous system depression when combined with other medication or drugs.

Common adverse effects of benzodiazepines are somnolence, impaired balance, ataxia, loss of coordination, impaired thinking and self-assessment capability, muscle weakness, confusion, slurred speech, blurred vision, amnesia, dizziness, drowsiness, lethargy, fatigue and palpitations. At high doses, they could induce delirium, auditory and visual hallucinations, seizures, deep sleep and coma.

To study the potential addictive nature of bromazolam a two-lever drug discrimination test was performed. Rats trained to discriminate against the benzodiazepine midazolam were used to evaluate the abuse potential of bromazolam. They found that bromazolam resulted in full dose-dependent substitution with an ED50 of 0.54 mg/kg. In comparison the ED50 of midazolam and diazepam were 0.09 and 0.66 respectively.

Pharmacology

Pharmacokinetics

Metabolism

Not many studies have been conducted on the biotransformation of bromazolam, mainly because this drug is relatively new. However, in a study of Wagmann et al. (2020), the biotransformation of bromazolam is studied in depth. The results of this study are described in the text below.

Blood plasma and urine of two individuals suspected of taking bromazolam were analysed for bromazolam and its metabolites. Bromazolam was detected in all four of the samples. One of the urine samples contained 8 bromazolam metabolites these were: phenyl-hydroxy bromazolam, 4-hydroxy bromazolam, α-hydroxy bromazolam, α-4-dihydroxy bromazolam, bromazolam N-glucuronide, phenyl-hydroxy bromazolam glucuronide, α-hydroxy bromazolam glucuronide, and 4-hydroxy bromazolam glucuronide. In the blood plasma sample of the same individual only the three mono-hydroxylated metabolites were found.

The urine of the other individual only contained two metabolites, which were also found in the other urine sample, and the blood plasma did not show any metabolite of bromazolam present in the body.

A study where pooled human liver S9 fractions (pHLS9) were incubated with bromazolam was conducted. Seven, out of the eight urine, bromazolam metabolites were found in the pHLS9 samples. Phenyl-hydroxylated glucuronide bromazolam was not found in the pHLS9 samples.

Several monooxygenases and glucuronosyltransferases have been screened, in vitro, for activity of the biotransformation of bromazolam. Out of the eight metabolites found in a urine sample seven metabolites have been linked to monooxygenases and glucuronosyltransferases activity.

Phase I

Phenyl-hydroxy bromazolam, 4-hydroxy bromazolam, α-hydroxy bromazolam, and α-4-dihydroxy bromazolam. The formation of phenyl-hydroxy bromazolam was catalysed by CYP2B6, CYP2C19, and CYP3A4. 4-hydroxy bromazolam, as well as α-hydroxy bromazolam, were formed by CYP2B6, CYP2C19, CYP3A4, and CYP3A5. Additionally, CYP2C9 was found to catalyse the formation of α-hydroxy bromazolam as well. α-4-dihydroxy bromazolam was only found in incubations with CYP3A4.

Phase II

Bromazolam N-glucuronide, phenyl-hydroxy bromazolam glucuronide, α-hydroxy bromazolam glucuronide, and 4-hydroxy bromazolam glucuronide, were detected as phase II metabolites.

Bromazolam N-glucuronidation was found to be catalysed by UGT1A4 and UGT2B10.  The formation of α-hydroxy bromazolam glucuronide was catalysed by UGT2B4. And 4-hydroxy bromazolam glucuronidation was catalysed by UGT1A3, UGT1A6, UGT1A9, UGT2B7 and UGT2B15.

The enzyme responsible for the catalysis for the phenyl-hydroxy bromazolam glucuronidation formation was not identified.

Pharmacodynamics

Benzodiazepine like compounds are acting as positive allosteric modulators to the gamma-aminobutyric acid GABAA receptor. GABA is the main inhibitor of neurotransmitters in the brain and modulates the activity of many neurons.

Benzodiazepines bind to the GABAA receptor inducing a conformational change leading to an increased affinity to GABA.

The allosteric binding site is situated in a “pocket” created by the alpha and gamma subunits. The pharmacological effects on benzodiazepines vary based on which alpha subunit of the GABAA receptor the benzodiazepine binds to.

The sedative, anterograde amnesic, anticonvulsant actions, and the addictive nature of benzodiazepines, are due to the binding to the α1 subunit of the (GABA)A receptor. Binding to the α2 subunit will cause the anxiolytic effects, and binding to the α2, α3, and α5 subunits will lead to the myorelaxant effects.

According to research done by the WHO bromazolam binds to the α1, α2, and α5 subunits.

Chemistry

Synthesis

The synthetic pathway of the synthesis is executed as follows: In the initial step, 2-Amino-5-bromobenzophenone undergoes acylation, leveraging its amino group with a lone pair on the nitrogen atom. This lone pair facilitates a nucleophilic attack, where the nitrogen attacks the carbon of chloroacetyl chloride, inducing a negatively charged oxygen. Subsequently, the oxygen re-establishes the carbon-oxygen double bond, expelling a chloride ion, leading to the formation of bromoacetamide-2-chloro-5-benzophenone.

Following this, bromoacetamide-2-chloro-5-benzophenone engages in a nucleophilic substitution reaction with ammonium hydroxide as a nucleophile, replacing the second chloride ion with ammonia. This reaction yields 2-amino-N-(2-benzoyl-4-bromophenyl)acetamide.

Upon the formation of 2-amino-N-(2-benzoyl-4-bromophenyl)acetamide, an intramolecular reaction ensues, resulting in 7-bromo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one, characterized by a seven-membered ring known as diazepine.

Subsequently, through the aid of acetohydrazide, another acylation event takes place, giving rise to a 1,2,4-triazole ring and ultimately yielding the synthesis of Bromazolam.[14][17][18][19] The synthesis of Bromazolam is shown below.

Proposed synthesis bromazolam

Society and culture

Legal status

In the United States, bromazolam is unscheduled at the federal level. However a number of states such as Virginia have placed bromazolam into Schedule 1 at the state level, but this does not include the chloro analog phenazolam.

Despite being unscheduled there have been several arrests in the United States for mismarketing bromazolam as alprazolam, typically in the shape of brand name Xanax tablets which constitutes a counterfeit drug charge among others.

In Illinois, at least 1 person has been arrested for “unlawful possession of a controlled substance, a Class 4 felony.” for the possession of less than 15 grams (½ oz.) of bromazolam, similar to being charged for unlawful possession of alprazolam in Illinois. It’s unknown if this arrest involved counterfeit Xanax shaped tablets or powder. However bromazolam is not scheduled in Illinois.

In June 2022, the U.S. Department of Justice reported that bromazolam seizures were “surging” across the United States, driven in part by increasing detections alongside fentanyl. Illicit opioids such as heroin or fentanyl analogues are mixed with bromazolam and sold at the street level; the product is sometimes referred to as “benzo-dope.”The Indiana Department of Health reported that bromazolam represented 73% of all novel or designer benzodiazepines detected in the first six months of 2023. Of 1,051 blood toxicology samples containing bromazolam reported between January and June 2023, 83% were fentanyl positive, suggesting that bromazolam is commonly mixed with fentanyl.

In the United Kingdom, Bromazolam is a Class C controlled substance.